Hypercortisolism May Affect COVID-19 Severity in Cushing’s Patients

Hypercortisolism May Affect COVID-19 Severity in Cushing’s Patients

292456

Hypercortisolism May Affect COVID-19 Severity in Cushing’s Patients

Clinical outcomes of COVID-19 in people with Cushing’s syndrome seem to depend on the severity of hypercortisolism, or how high blood cortisol levels are in these patients, according to a recent case series study. “Severe hypercortisolism is a warning sign that [Cushing’s syndrome] affected by COVID-19 could require emergency care despite a lack of clinical presentations and low inflammation biomarkers,” the investigators wrote. The study, “Clinical course and outcome of patients with ACTH-dependent Cushing’s syndrome…

You must be logged in to read/download the full post.